Works matching IS 02724391 AND DT 2023 AND VI 84 AND IP 3

Results: 16

Investigation of the factors responsible for the low oral bioavailability of alizarin using a sensitive LC‐MS/MS method: In vitro, in situ, and in vivo evaluations.
Published in:
Drug Development Research, 2023, v. 84, n. 3, p. 579, doi. 10.1002/ddr.22047
By:
- Seo, Seong‐Wook;
- Han, Dong‐Gyun;
- Baek, Young Mee;
- Park, Min Chul;
- Yoo, Jin‐Wook;
- Jung, Yunjin;
- Maeng, Han‐Joo;
- Myung, Heejoon;
- Yoon, In‐Soo
Publication type:
Article
Kaempferol suppresses glioma progression and synergistically enhances the antitumor activity of gefitinib by inhibiting the EGFR/SRC/STAT3 signaling pathway.
Published in:
Drug Development Research, 2023, v. 84, n. 3, p. 592, doi. 10.1002/ddr.22048
By:
- Zhou, Jiabin;
- Liu, Yuhan;
- Chen, Jun;
- Xiong, Nanxiang;
- Yi, Dongye
Publication type:
Article
Hit discovery of novel 2‐phenyl‐substituted 4‐amino–6,7‐dihydro‐5H‐cyclopenta[d]pyrimidines as potential anti‐glioblastoma therapeutics: Design, synthesis, biological evaluation, and computational screening.
Published in:
Drug Development Research, 2023, v. 84, n. 3, p. 561, doi. 10.1002/ddr.22046
By:
- Khairnar, Sanjay;
- Sonawane, Anjali;
- Cheke, Rameshwar S.;
- Kharkar, Prashant S.;
- Gaikwad, Vishwas;
- Patil, Sambhaji;
- Aware, Valmik
Publication type:
Article
PX‐12 synergistically enhances the therapeutic efficacy of vorinostat under hypoxic tumor microenvironment in oral squamous cell carcinoma in vitro.
Published in:
Drug Development Research, 2023, v. 84, n. 3, p. 556, doi. 10.1002/ddr.22045
By:
- Akhlaq, Rafia;
- Khan, Tajwali;
- Ahmed, Tehmina;
- Musharraf, Syed G.;
- Ali, Arslan
Publication type:
Article
Shikonin potentiates therapeutic efficacy of oxaliplatin through reactive oxygen species‐mediated intrinsic apoptosis and endoplasmic reticulum stress in oxaliplatin‐resistant colorectal cancer cells.
Published in:
Drug Development Research, 2023, v. 84, n. 3, p. 542, doi. 10.1002/ddr.22044
By:
- Zhang, Zhengguang;
- Shen, Cunsi;
- Zhou, Fuqiong;
- Zhang, Yajie
Publication type:
Article
Butyrate prevents the migration and invasion, and aerobic glycolysis in gastric cancer via inhibiting Wnt/β‐catenin/c‐Myc signaling.
Published in:
Drug Development Research, 2023, v. 84, n. 3, p. 532, doi. 10.1002/ddr.22043
By:
- Liang, Yizhi;
- Rao, Zilan;
- Du, Dongwei;
- Wang, Yiwen;
- Fang, Taiyong
Publication type:
Article
Comparative anticonvulsant activity of the GABAkine KRM‐II‐81 and a deuterated analog.
Published in:
Drug Development Research, 2023, v. 84, n. 3, p. 527, doi. 10.1002/ddr.22042
By:
- Ping, Xingjie;
- Meyer, Michelle J.;
- Zahn, Nicolas M.;
- Golani, Lalit K.;
- Sharmin, Dishary;
- Pandey, Kamal P.;
- Revanian, Sepideh;
- Mondal, Prithu;
- Jin, Xiaoming;
- Arnold, Leggy A.;
- Cerne, Rok;
- Cook, James M.;
- Divović, Branka;
- Savić, Miroslav M.;
- Lippa, Arnold;
- Smith, Jodi L.;
- Witkin, Jeffrey M.
Publication type:
Article
Synthetic amino acids‐based short amphipathic peptides exhibit antifungal activity by targeting cell membrane disruption.
Published in:
Drug Development Research, 2023, v. 84, n. 3, p. 514, doi. 10.1002/ddr.22041
By:
- Aaghaz, Shams;
- Sharma, Komal;
- Maurya, Indresh K.;
- Rudramurthy, Shivaprakash M.;
- Singh, Shreya;
- Kumar, Vinod;
- Tikoo, Kulbhushan;
- Jain, Rahul
Publication type:
Article
Evaluation of advanced, pathophysiologic new targets for imaging of CNS.
Published in:
Drug Development Research, 2023, v. 84, n. 3, p. 484, doi. 10.1002/ddr.22040
By:
- Singh, Priya;
- Singh, Deepika;
- Srivastava, Pooja;
- Mishra, Gauri;
- Tiwari, Anjani K.
Publication type:
Article
Synthesis, antitubercular evaluation, and molecular docking studies of hybrid pyridinium salts derived from isoniazid.
Published in:
Drug Development Research, 2023, v. 84, n. 3, p. 470, doi. 10.1002/ddr.22039
By:
- Bhavani, Gollagani Vijaya;
- Kondapuram, Sree Karani;
- Shamsudeen, Aifa Fathima;
- Coumar, Mohane Selvaraj;
- Selvin, Joseph;
- Kannan, Tharanikkarasu
Publication type:
Article
The research progress on the anxiolytic effect of plant‐derived flavonoids by regulating neurotransmitters.
Published in:
Drug Development Research, 2023, v. 84, n. 3, p. 458, doi. 10.1002/ddr.22038
By:
- Wang, Chao;
- Yang, Shanbo;
- Deng, Junwen;
- Shi, Lingyu;
- Chang, Jing;
- Meng, Jingsen;
- Liu, Wenjing;
- Zeng, Jun;
- Xing, Kunyue;
- Wen, Jialian;
- Liang, Bing;
- Xing, Dongming
Publication type:
Article
Coumarin derivatives with potential anticancer and antibacterial activity: Design, synthesis, VEGFR‐2 and DNA gyrase inhibition, and in silico studies.
Published in:
Drug Development Research, 2023, v. 84, n. 3, p. 433, doi. 10.1002/ddr.22037
By:
- Emam, Soha H.;
- Hassan, Rasha A.;
- Osman, Eman O.;
- Hamed, Mohammed I. A.;
- Abdou, Amr M.;
- Kandil, Mai M.;
- Elbaz, Eman Maher;
- Mikhail, Demiana S.
Publication type:
Article
Synthesis and anti‐HIV activity of non‐nucleoside reverse‐transcriptase inhibitor DB02 phosphate derivatives based on water‐soluble optimization.
Published in:
Drug Development Research, 2023, v. 84, n. 3, p. 423, doi. 10.1002/ddr.22036
By:
- Wang, Jing‐Bo;
- Ma, Meng‐Di;
- Lu, Nan;
- Yang, Yu‐Zhuo;
- Yang, Jin‐Xuan;
- Li, Yi‐Ming;
- Xie, Cong‐Qiang;
- Ma, Ning‐Yu;
- Luo, Rong‐Hua;
- Wang, Yue‐Ping;
- Yang, Liu‐Meng;
- Zhang, Hong‐Bin;
- Zheng, Yong‐Tang;
- He, Yan‐Ping
Publication type:
Article
Design, synthesis, and antitumor evaluation of trimethoxyflavonoid with arylurea structure against hepatocellular carcinoma.
Published in:
Drug Development Research, 2023, v. 84, n. 3, p. 406, doi. 10.1002/ddr.22035
By:
- Sun, Xueyan;
- Zhao, Yin;
- Zhao, Jingduo;
- Xie, Zhizhong;
- Lei, Xiaoyong;
- Liu, Xingyun;
- Li, Yong;
- Huang, Sheng;
- Wang, Zhe;
- Tang, Guotao
Publication type:
Article
Cyclic carbamates in medicine: A clinical perspective.
Published in:
Drug Development Research, 2023, v. 84, n. 3, p. 397, doi. 10.1002/ddr.22033
By:
- Prasher, Parteek;
- Mall, Tanisqa;
- Sharma, Mousmee
Publication type:
Article
Issue Information.
Published in:
Drug Development Research, 2023, v. 84, n. 3, p. 395, doi. 10.1002/ddr.21945
Publication type:
Article